Literature DB >> 19375515

The spectrum of ocular phenotypes caused by mutations in the BEST1 gene.

Camiel J F Boon1, B Jeroen Klevering, Bart P Leroy, Carel B Hoyng, Jan E E Keunen, Anneke I den Hollander.   

Abstract

Bestrophin-1 is an integral membrane protein, encoded by the BEST1 gene, which is located in the basolateral membrane of the retinal pigment epithelium. The bestrophin-1 protein forms a Ca(2+) activated Cl(-) channel and is involved in the regulation of voltage-dependent Ca(2+) channels. In addition, bestrophin-1 appears to play a role in ocular development. Over 120 different human BEST1 mutations have been described to date, associated with a broad range of ocular phenotypes. The purpose of this review is to describe this spectrum of phenotypes, which includes Best vitelliform macular dystrophy and adult-onset foveomacular vitelliform dystrophy, autosomal dominant vitreoretinochoroidopathy, the MRCS (microcornea, rod-cone dystrophy, cataract, posterior staphyloma) syndrome, and autosomal recessive bestrophinopathy. The genotype-phenotype correlations that are observed in association with BEST1 mutations are discussed. In addition, in vitro studies and animal models that clarify the pathophysiological mechanisms are reviewed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19375515     DOI: 10.1016/j.preteyeres.2009.04.002

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  102 in total

1.  Clinical utility gene card for: BEST1-related dystrophies (Bestrophinopathies).

Authors:  Simon C Ramsden; Alice E Davidson; Bart P Leroy; Anthony T Moore; Andrew R Webster; Graeme C M Black; Forbes D C Manson
Journal:  Eur J Hum Genet       Date:  2012-01-11       Impact factor: 4.246

2.  Multimodal fundus imaging in Best vitelliform macular dystrophy.

Authors:  Daniela C Ferrara; Rogério A Costa; Stephen Tsang; Daniela Calucci; Rodrigo Jorge; K Bailey Freund
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-04-23       Impact factor: 3.117

Review 3.  Bestrophins and retinopathies.

Authors:  Qinghuan Xiao; H Criss Hartzell; Kuai Yu
Journal:  Pflugers Arch       Date:  2010-03-28       Impact factor: 3.657

4.  Quantitative Fundus Autofluorescence in Best Vitelliform Macular Dystrophy: RPE Lipofuscin is not Increased in Non-Lesion Areas of Retina.

Authors:  Janet R Sparrow; Tobias Duncker; Russell Woods; François C Delori
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

5.  Molecular consequences of BEST1 gene mutations in canine multifocal retinopathy predict functional implications for human bestrophinopathies.

Authors:  Karina E Guziewicz; Julianna Slavik; Sarah J P Lindauer; Gustavo D Aguirre; Barbara Zangerl
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-23       Impact factor: 4.799

6.  [Yellow spots within the macula].

Authors:  T Hager; B Käsmann-Kellner; B Seitz
Journal:  Ophthalmologe       Date:  2014-03       Impact factor: 1.059

Review 7.  Inherited Congenital Cataract: A Guide to Suspect the Genetic Etiology in the Cataract Genesis.

Authors:  Olga Messina-Baas; Sergio A Cuevas-Covarrubias
Journal:  Mol Syndromol       Date:  2017-02-07

Review 8.  Underdeveloped RPE Apical Domain Underlies Lesion Formation in Canine Bestrophinopathies.

Authors:  Karina E Guziewicz; Emily McTish; Valerie L Dufour; Kathryn Zorych; Anuradha Dhingra; Kathleen Boesze-Battaglia; Gustavo D Aguirre
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 9.  CLINICAL PROGRESS IN INHERITED RETINAL DEGENERATIONS: GENE THERAPY CLINICAL TRIALS AND ADVANCES IN GENETIC SEQUENCING.

Authors:  Brian P Hafler
Journal:  Retina       Date:  2017-03       Impact factor: 4.256

10.  BESTROPHIN1 mutations cause defective chloride conductance in patient stem cell-derived RPE.

Authors:  Yasmin Moshfegh; Gabriel Velez; Yao Li; Alexander G Bassuk; Vinit B Mahajan; Stephen H Tsang
Journal:  Hum Mol Genet       Date:  2016-05-18       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.